Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same
Abstract
To provide a microorganism and an ingredient thereof that contribute to prevention and treatment of immune diseases including allergy, autoimmune diseases and inflammatory bowel diseases (e.g., large-intestinal ulcer), a method of effectively selecting the microorganism, and a method of efficiently inducing immunoregulatory cells that play an important role on maintaining immunological homeostasis using the microorganism or the ingredient thereof. The present invention provides a Lactococcus and an ingredient thereof which induce production of IL-b from mammalian dendritic or spleen cells, a method of obtaining the microorganism or the ingredient thereof by co-culturing a microorganism such as Lactococcus strains with mammalian dendritic or spleen cells to select a microbial cell having a high IL-b production ability, a method of selecting the microorganism or the ingredient thereof by co-culturing an intestinal epithelial cell with a microorganism such as the lactic acid bacteria and selecting the cells on the basis of a caspase-1 activity and the ability of inducing the production of IL-18, and a food product or material and an animal feeding stuff or medical and pharmaceutical products which contain the lactic acid bacteria as an effective ingredient.
Claims
exact text as granted — not AI-modified1 . A method of obtaining a microorganism or its cellular components having an immunoregulatory function derived from the microorganism, which induces production of Interleukin-10 from mammalian dendritic or spleen cells, comprising:
co-culturing a bacterium to be tested with the mammalian dendritic or spleen cell; and selecting a microbial strain having an ability of inducing the production of Interleukin-10.
2 . A method of obtaining a microorganism or its cellular components having an immunoregulatory function of claim 1 , wherein the bacterium to be tested is a Lactococcus.
3 . A method of selecting a microorganism or its cellular components having an immunoregulatory function, which induces the production of Interleukin-10 from mammalian dendritic or spleen cells, comprising:
co-culturing cells to be tested with intestinal epithelial cells to induce cells having a low ability of inducing caspase-I activity and an enhanced ability of inducing the production of Interleukin-18.Join the waitlist — get patent alerts
Track US2011269165A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.